Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-36229366

RESUMO

OBJECTIVES: End-stage heart failure patients are functionally compromised by multiple physiologic mechanisms, placing them at increased risk of peri- and post-operative complications. This study aimed to evaluate if dental treatment performed before advanced cardiac interventions, including orthotopic heart transplant and mechanical circulatory support, increases the risk of adverse events. STUDY DESIGN: A retrospective chart review spanning January 2011 to December 2020 was performed. Inpatients with end-stage heart disease were evaluated by the hospital dentistry service at UCLA Ronald Reagan Medical Center. Three hundred and five consults met the inclusion criteria. The patients were divided into 2 groups: those who underwent dental treatment and those who did not require dental treatment. The wait time from dental consultation to cardiac intervention (days), dental complications, medical adverse events, and deaths were evaluated. RESULTS: Dental complications were only experienced in the form of intraoral bleeding. There was no significant difference in the number of medical adverse events or deaths between groups. CONCLUSIONS: The elimination of oral infection before advanced cardiac interventions does not increase the risk of morbidity or mortality.


Assuntos
Insuficiência Cardíaca , Extração Dentária , Humanos , Estudos Retrospectivos , Insuficiência Cardíaca/cirurgia
2.
J Oral Maxillofac Surg ; 80(1): 22-28, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34363765

RESUMO

PURPOSE: Elimination of dental sources of infection prior to cardiovascular surgery (CVS) is performed to reduce perioperative infection and complications. This study aims to evaluate if preoperative dental intervention is associated with increased risk of adverse events. METHODS: A retrospective medical record review of inpatient consultations (n = 1513) completed by the Hospital Dentistry Service at University of California Los Angeles Medical Center from January 2011 to December 2020 was performed. Seven hundred thirty-eight consults met the inclusion criteria and were divided into 4 groups: Group A were patients that were dentally unhealthy and received surgical dental intervention (n = 265), Group B were patients that were dentally unhealthy and underwent non-surgical dental treatment (n = 14), Group C were patients that were dentally unhealthy and did not receive the recommended dental treatment (n = 29), and Group D were patients that were dentally healthy requiring no intervention (n = 430). They were evaluated for major adverse events in 3 categories: dental complications, medical adverse events and death. RESULTS: Dental complications were only experienced in Group A, all of which were bleeding. Only 2 patients were found to have major bleeding, which was more likely due to anticoagulation and CVS rather than dental extractions. There was no significant difference in the number of medical adverse events or number of deaths during the postoperative period between groups. CONCLUSIONS: The results of this study suggest that elimination of oral infection prior to CVS does not increase the risk of morbidity or mortality.


Assuntos
Hemorragia , Cuidados Pré-Operatórios , Assistência Odontológica , Humanos , Período Pós-Operatório , Estudos Retrospectivos
3.
Spec Care Dentist ; 40(5): 437-442, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32777084

RESUMO

AIM: To assess the efficacy of dexmedetomidine (DEX) on the intravenous moderate sedation (IVMS) regimen, while treating patients of the special patient care (SPC) population. This study aims to incorporate DEX into the typical IVMS drug regimen in order to reduce the amount of benzodiazepines (BZD) and opioids administered and as a result reduce the amount of unwanted side effects. METHOD AND RESULTS: A retrospective study was performed in the University of California Los Angeles (UCLA) SPC Clinic, where 42 patients were seen with and without DEX for dental treatment under IVMS. Medications administered, vital signs, and complications were recorded at 5 minute intervals over the first hour. All BZDs and opioids were converted to their IV midazolam and IV fentanyl equivalents, respectively. An opioid conversion equation was developed to summate the total amount of anesthetic agents administered. Data were analyzed by t-test. The amount of BZDs administered was reduced, however the decrease was not statistically significant (P = .066). There was a significant reduction in opioids (P < .05) and total anesthetic agents (P < .05) administered. CONCLUSION: The addition of DEX to the anesthetic regimen results in a reduction of overall medications administered.


Assuntos
Analgésicos Opioides , Dexmedetomidina , Benzodiazepinas , Sedação Consciente , Humanos , Hipnóticos e Sedativos , Los Angeles , Estudos Retrospectivos
4.
Spec Care Dentist ; 35(6): 268-71, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26084886

RESUMO

BACKGROUND: Osteoradionecrosis (ORN) is an unfortunate complication of radiation therapy to the head and neck. Treatment has historically centered around hyperbaric oxygen therapy and surgical removal of necrotic bone. Recently, a new theory on the pathogenesis of ORN has proposed treatment with pentoxifylline (PTX) and tocopherol/vitamin E. The aim of this retrospective analysis was to evaluate the effectiveness of pentoxifylline and tocopherol in the management of patients with ORN. METHODS: The hospital dentistry group managed 13 patients that presented to our service with exposed bone after cancercidal doses of radiation to the head and neck. The patients were prescribed PTX 400 mg bid and tocopherol 1,000 IU QD. RESULTS: Eleven of the 13 patients exhibited improvement and resolution. No adverse events were noted during treatment. CONCLUSION: This medical modality of treating ORN appears safe and effective, inducing bone and mucosal healing.


Assuntos
Antioxidantes/uso terapêutico , Neoplasias de Cabeça e Pescoço/radioterapia , Osteorradionecrose/tratamento farmacológico , Pentoxifilina/uso terapêutico , Protetores contra Radiação/uso terapêutico , Tocoferóis/uso terapêutico , Idoso , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
5.
Artigo em Inglês | MEDLINE | ID: mdl-25047928

RESUMO

OBJECTIVE: This report aims to describe the dental protocol for treating in the intensive care unit patients with end-stage heart failure who have had ventricular assist devices (VADs) emergently implanted as a bridge to heart transplant. This protocol permitted the rendering of safe and effective dental care in this setting and did not result in near-term (1-30 days) excessive hemorrhage, local and systemic infection, or contamination of the VAD. STUDY DESIGN: This descriptive cross-sectional study by the University of California, Los Angeles, Hospital Dental Service examined the dental care of 9 patients (mean age, 50 ± 12.9 years) with class IV stage D heart failure. RESULTS: Nine patients, 22 days (mean) after VAD placement, received dental treatment after intravenous prophylactic antibiotics and maintenance of prior anticoagulation, antiplatelet, or antithrombin regimen. Eight patients had extractions (mean, 4; range, 1-12), and one of them also required scaling and root planing (SRP) of the remaining teeth. A ninth individual only required SRP of 4 quadrants. No adverse outcomes developed. CONCLUSIONS: Emergent removal of active dental disease in patients with VAD awaiting heart transplant can be safely accomplished using established protocols with extended vigilance.


Assuntos
Assistência Odontológica para Doentes Crônicos , Insuficiência Cardíaca/complicações , Insuficiência Cardíaca/terapia , Coração Auxiliar , Unidades de Terapia Intensiva , Adulto , Idoso , Antibioticoprofilaxia , Anticoagulantes/administração & dosagem , Estudos Transversais , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
6.
J Bone Miner Res ; 25(6): 1337-49, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20200938

RESUMO

Necrotic bone exposure in the oral cavity has recently been reported in patients treated with nitrogen-containing bisphosphonates as part of their therapeutic regimen for multiple myeloma or metastatic cancers to bone. It has been postulated that systemic conditions associated with cancer patients combined with tooth extraction may increase the risk of osteonecrosis of the jaw (ONJ). The objective of this study was to establish an animal model of bisphosphonate-related ONJ by testing the combination of these risk factors. The generation of ONJ lesions in rats resembling human disease was achieved under the confluence of intravenous injection of zoledronate (ZOL; 35 microg/kg every 2 weeks), maxillary molar extraction, and vitamin D deficiency [VitD(-)]. The prevalence of ONJ in the VitD(-)/ZOL group was 66.7%, which was significantly higher (p < .05, Fisher exact test) than the control (0%), VitD(-) (0%), and ZOL alone (14.3%) groups. Similar to human patients, rat ONJ lesions prolonged the oral exposure of necrotic bone sequestra and were uniquely associated with pseudoepitheliomatous hyperplasia. The number of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick-end label-positive (TUNEL(+)) osteoclasts significantly increased on the surface of post-tooth extraction alveolar bone of the VitD(-)/ZOL group, where sustained inflammation was depicted by [(18)F]fluorodeoxyglucose micro-positron emission tomography (microPET). ONJ lesions were found to be associated with dense accumulation of mixed inflammatory/immune cells. These cells, composed of neutrophils and lymphocytes, appeared to juxtapose apoptotic osteoclasts. It is suggested that the pathophysiologic mechanism(s) underpinning ONJ may involve the interaction between bisphosphonates and compromised vitamin D functions in the realm of skeletal homeostasis and innate immunity.


Assuntos
Difosfonatos/efeitos adversos , Doenças Maxilomandibulares/etiologia , Osteonecrose/etiologia , Deficiência de Vitamina D/complicações , Animais , Apoptose/efeitos dos fármacos , Difosfonatos/administração & dosagem , Difosfonatos/sangue , Difosfonatos/farmacologia , Modelos Animais de Doenças , Fêmur/efeitos dos fármacos , Fêmur/patologia , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Imidazóis/administração & dosagem , Imidazóis/efeitos adversos , Imidazóis/sangue , Imidazóis/farmacologia , Inflamação/genética , Inflamação/patologia , Doenças Maxilomandibulares/patologia , Análise de Sequência com Séries de Oligonucleotídeos , Osteoclastos/efeitos dos fármacos , Osteoclastos/patologia , Osteogênese/efeitos dos fármacos , Osteonecrose/patologia , Ratos , Ratos Sprague-Dawley , Extração Dentária/efeitos adversos , Vitamina D/administração & dosagem , Vitamina D/farmacologia , Ácido Zoledrônico
7.
Artigo em Inglês | MEDLINE | ID: mdl-20097109

RESUMO

BACKGROUND: Atherosclerosis may be initiated/accelerated by chronic dental infection (CDI). Noninvasively visualizing the carotid arteries is an accepted surrogate marker for determining coronary artery atherosclerosis (CAA). We hypothesized that 36 individuals with radiographic carotid atheromas would have more radiographic CDI than risk-matched individuals without atheromas. METHODS: We determined the arithmetic sum of individuals' periapical and furcal lesions, pericoronitis sites, carious roots, teeth with pulpal caries, and vertical bony defects (>4 mm). RESULTS: Individuals with atheromas had a significantly (P < .01) greater mean score of 15.5 +/- 10.4 compared with control subjects (7.9 +/- 8.1). Similarly significant (P < .05) was the difference in the mean numbers of mesial and distal vertical bony defects in the atheroma group (4.1 +/- 3.9 and 4.8 +/- 3.8, respectively) compared with control subjects (1.6 +/- 2.4 and 1.8 +/- 2.7, respectively). CONCLUSIONS: Individuals with atheromas on their radiographs (and high probability of CAA) had significantly greater amounts of CDI than individuals without atheromas.


Assuntos
Aterosclerose/complicações , Doenças das Artérias Carótidas/complicações , Cárie Dentária/diagnóstico por imagem , Doenças Periodontais/diagnóstico por imagem , Adulto , Perda do Osso Alveolar/diagnóstico por imagem , Aterosclerose/diagnóstico por imagem , Doenças das Artérias Carótidas/diagnóstico por imagem , Artéria Carótida Interna/diagnóstico por imagem , Artéria Carótida Interna/patologia , Estudos de Casos e Controles , Doença Crônica , Estudos de Coortes , Diabetes Mellitus Tipo 2/complicações , Feminino , Defeitos da Furca/diagnóstico por imagem , Humanos , Hiperlipidemias/complicações , Masculino , Pessoa de Meia-Idade , Doenças Periapicais/diagnóstico por imagem , Pericoronite/diagnóstico por imagem , Radiografia Panorâmica , Fatores de Risco , Cárie Radicular/diagnóstico por imagem , Fumar , Ultrassonografia Doppler
8.
J Calif Dent Assoc ; 34(9): 735-42, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17022298

RESUMO

The utilization of combined chemoradiation therapy has recently increased in the treatment of head and neck cancers. This patient population is significantly more prone to various oral complications during and after medical therapy. Oral complications and long-term effects include mucositis, xerostomia, alterations in taste, vascular compromise, mucosal thinning and increased risk of rampant caries and periodontal disease. The most serious oral complication that can arise is osteoradionecrosis. Managing patients properly prior to medical treatment can help decrease these potential complications during and after treatment. This purpose of this article is to review the different radiation and chemotherapy regimens used to treat patients with head and neck cancers, as well as protocols in the dental management of these patients before, during, and after medical treatment.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias de Cabeça e Pescoço/radioterapia , Doenças da Boca/prevenção & controle , Doenças Dentárias/prevenção & controle , Assistência Odontológica , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Humanos , Doenças Maxilomandibulares/prevenção & controle , Terapia Neoadjuvante , Osteorradionecrose/prevenção & controle
9.
Gen Dent ; 54(4): 254-7, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16903197

RESUMO

This study sought to compare the cutting efficiency of different diamond burs on initial use as well as during repeated use, alternating with sterilization. Long, round-end, tapered diamond burs with similar diameter, profile, and diamond coarseness (125-150 microm grit) were used. A high-torque, high-speed electric handpiece (set at 200,000 rpm) was utilized with a coolant flow rate of 25 mL/min. Burs were tested under a constant load of 170 g while cuts were made on a machinable ceramic substrate block. Each bur was subjected to five consecutive cuts for 30 seconds of continuous operation and the cutting depths were measured. All burs performed similarly on the first cut. Cutting efficiencies for three of the bur groups decreased significantly after the first cycle; however, by the fifth cycle, all bur groups performed similarly without any significant differences (p > 0.05). A scanning electron microscope revealed significant crystal loss after each use.


Assuntos
Equipamentos Odontológicos de Alta Rotação , Diamante , Preparo do Dente/instrumentação , Cerâmica/química , Diamante/química , Desenho de Equipamento , Reutilização de Equipamento , Humanos , Teste de Materiais , Microscopia Eletrônica de Varredura , Esterilização , Estresse Mecânico , Propriedades de Superfície , Temperatura , Fatores de Tempo , Torque
10.
J Clin Pediatr Dent ; 30(1): 45-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16302599

RESUMO

This in vitro study evaluated the shear bond strength of a hybrid composite resin bonded to primary dentin prepared with an Er, Cr:YSGG hydrokinetic laser compared to conventional bur prepared primary dentin. The results suggest that primary dentin surfaces treated with the Er, Cr:YSGG laser, with or without etching, may provide comparable or increased composite resin bond strengths depending upon bonding agent used.


Assuntos
Resinas Acrílicas/química , Resinas Compostas/química , Colagem Dentária/métodos , Preparo da Cavidade Dentária/métodos , Terapia a Laser , Poliuretanos/química , Alumínio/uso terapêutico , Análise de Variância , Humanos , Resistência ao Cisalhamento , Ítrio/uso terapêutico
11.
J Contemp Dent Pract ; 5(2): 70-80, 2004 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-15150635

RESUMO

About 40% to 50% of Down syndrome (DS) patients can have significant congenital heart defects such as patent ductus arteriosus, Tetralogy of Fallot, and septal defects. Patients with large septal defects may develop Eisenmenger syndrome (ES), which is defined by the cardiac septal defect and pulmonary hypertension coupled with a reverse right to left shunting of blood flow. DS patients that suffer from this condition require special considerations in the delivery of their dental care to prevent further medical complications or emergencies such as infection, cyanotic episodes, and thromboemboli. Collaboration with the cardiologist is also essential to ensure a complete and comprehensive pre-operative work up. The purpose of this article is to describe the dental management of DS patients with ES under general anesthesia.


Assuntos
Assistência Odontológica para Doentes Crônicos , Síndrome de Down/complicações , Complexo de Eisenmenger/complicações , Adulto , Anestesia Dentária , Anestesia Geral , Antibioticoprofilaxia , Feminino , Comunicação Interventricular/complicações , Humanos , Extração Dentária
12.
Spec Care Dentist ; 22(4): 142-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12449457

RESUMO

Numerous oral complications have been documented as a consequence of chemotherapy for the treatment of cancer. One not so well documented consequence of this treatment is avascular necrosis or osteonecrosis of the underlying bone. In this case report, osteonecrosis of the maxilla in a 48-year-old female patient who was treated for acute myelogenous leukemia is presented. The patient had successfully completed both induction and consolidation chemotherapy without steroid administration. Possible causes and difficulties in diagnosis were reviewed.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Doenças Maxilares/induzido quimicamente , Osteonecrose/induzido quimicamente , Antibacterianos/efeitos adversos , Antibióticos Antineoplásicos/efeitos adversos , Antifúngicos/efeitos adversos , Antineoplásicos/efeitos adversos , Antivirais/efeitos adversos , Dente Suporte , Prótese Parcial Fixa , Evolução Fatal , Feminino , Seguimentos , Humanos , Idarubicina/efeitos adversos , Hospedeiro Imunocomprometido , Arcada Parcialmente Edêntula/reabilitação , Leucemia Mieloide Aguda/tratamento farmacológico , Doenças Maxilares/cirurgia , Pessoa de Meia-Idade , Osteonecrose/cirurgia , Cicatrização
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...